Article
PPAR gamma variant influences angiographic outcome and 10-year cardiovascular risk in male symptomatic coronary artery disease patients.
Diabetes care - 1 May 2009
Regieli Jakub J, Jukema J Wouter, Doevendans Pieter A, Zwinderman Aeilko H, van der Graaf Yolanda, Kastelein John J, Grobbee Diederick E
Abstract excerpt
OBJECTIVE: Activation of peroxisome proliferator-activated receptor (PPAR)-gamma signaling influences metabolic profiles and the propensity toward inflammation. Small-molecule stimulation of PPARgamma is investigated for secondary prevention of cardiovascular disease. The common PPARgamma Pro12Ala variant has functional and prognostic consequences. A protective effect of the 12Ala-allele carriership on diabetes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
